The first stop for professional medicines advice

Diclofenac sodium

Published
Topics: Anaesthesia and painDiclofenac sodiumEyes and vision · Musculo-skeletal disordersSafety in BreastfeedingSkin disordersStability in dosette boxes ·
Contents
  1. dm+d
  2. Articles
  3. Medicine Compliance Aid Stability
    1. Diclomax Retard · Galen Ltd
    2. generic · Dexcel Pharma Ltd
    3. Voltarol Rapid · Novartis Pharmaceuticals UK Ltd
    4. generic · Teva UK Ltd
    5. generic · Sandoz Ltd
    6. Motifene · Daiichi Sankyo UK Ltd
    7. Diclomax SR · Galen Ltd
    8. Rhumalgan XL · Sandoz Ltd
    9. Rhumalgan CR · Sandoz Ltd
  4. Lactation Safety Information
    1. For oral/ rectal/ parenteral use
    2. Topical
    3. For ophthalmic use
    4. For actinic keratitis

dm+d

419143009

Articles

NSAIDs monitoring

22 June 2021
Search Articles

Medicine Compliance Aid Stability

Diclomax RetardGalen Ltd

Galen Ltd
Diclomax Retard
Capsules 100mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from moisture
Store in airtight container. Protect from moisture.
3 April 2022
Usage of Medicines in Compliance Aids

genericDexcel Pharma Ltd

Dexcel Pharma Ltd
generic
Tablets gastro-resistant 25mg, 50mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from moisture.
12 May 2022
Usage of Medicines in Compliance Aids

Voltarol RapidNovartis Pharmaceuticals UK Ltd

Novartis Pharmaceuticals UK Ltd
Voltarol Rapid
Tablets 50mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from moisture
12 May 2022
Usage of Medicines in Compliance Aids

genericTeva UK Ltd

Teva UK Ltd
generic
Tablets gastro-resistant 50mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from moisture
Protect from moisture. Airtight container.
12 May 2022
Usage of Medicines in Compliance Aids

genericSandoz Ltd

Sandoz Ltd
generic
Tablets enteric-coated 25mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from moisture
Protect from moisture. Airtight container.
12 May 2022
Usage of Medicines in Compliance Aids

MotifeneDaiichi Sankyo UK Ltd

Daiichi Sankyo UK Ltd
Motifene
Capsules 75mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Airtight container.
3 April 2022
Usage of Medicines in Compliance Aids

Diclomax SRGalen Ltd

Galen Ltd
Diclomax SR
Capsules 75mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from moisture
Store in airtight container. Protect from moisture.
3 April 2022
Usage of Medicines in Compliance Aids

Rhumalgan XLSandoz Ltd

Sandoz Ltd
Rhumalgan XL
Capsules modified release 100mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Airtight container.
12 May 2022
Usage of Medicines in Compliance Aids

Rhumalgan CRSandoz Ltd

Sandoz Ltd
Rhumalgan CR
Capsules 75mg, 100mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
Protect from light. Protect from moisture. Airtight container.
12 May 2022
Usage of Medicines in Compliance Aids

Lactation Safety Information

For oral/ rectal/ parenteral use

For oral/ rectal/ parenteral use
Yes
Extensive experience of safe use in breastfeeding
Limited published evidence of safety
No adverse effects reported in breastfed infants
Small amounts in breast milk
Safety in Lactation: Non-steroidal anti-inflammatory drugs
29 July 2020
LactMed

Topical

Topical
Yes
Negligible milk levels anticipated as systemic absorption from topical formulations is low
Follow normal precautions for topical medicines (see summary)
Safety in Lactation: Drugs for the relief of soft-tissue inflammation and topical pain relief
29 July 2020

For ophthalmic use

For ophthalmic use
Yes
Safety in Lactation: Ocular peri-operative preparations
29 July 2020

For actinic keratitis

For actinic keratitis
Yes
Negligible milk levels anticipated as systemic absorption from topical formulations is low
Avoid contact of the breastfeeding infant with treated areas
30 October 2020